Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1316 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Novartis inks agreement to acquire Genoptix

The acquisition will enhance Novartis‘s tools and services that aim to improve health outcomes for patients by advancing the ability to define and monitor individualized treatment programs. Under

Eisai gets NerBloc marketing approval in Japan

NerBloc, a botulinum toxin type B neuromuscular-blocking agent has showed improvement in TWSTRS (Toronto Western Spasmodic Torticollis Rating Scale) total score from baseline to week four compared with

FDA warns against ED drug Man Up Now

Distributed by Synergy Distribution, Man Up Now is said to contain a variant of sildenafil, the active ingredient in Viagra. Reportedly, the variant, sulfoaildenafil, if interacts with other